Trial Profile
WCC 59: Pilot Study of Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Jul 2019 Status changed from completed to discontinued,according to ClinicalTrials.gov record.
- 23 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 31 Jan 2013 Planned end date changed from 1 Sep 2018 to 1 Sep 2017 as reported by ClinicalTrials.gov.